Istanbul, Turkey
June 16, 2003
This symposium was designed to improve the working knowledge and skills of clinicians treating patients with multiple sclerosis (MS). The programme focused on some qualitative indicators in the management of MS and disease modifying treatments.
OBJECTIVES
At the conclusion of this course the participant was able to:
- Have gained insight into a new validated tool to measure Quality of Life (QoL) in patients with MS;
- Be able to describe how magnetic resonance imaging can be used as a quality tool in the treatment of MS;
- Be able to discuss recent developments related to the quality of high-dose interferon treatment in relapsing MS.
This course is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.be
Quality Quantitative Indicators in Multiple Sclerosis is designated for a maximum of 2 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
EACCME credits are recognized as Physician’s Recognition Award by the American Medical Association.
The Royal College of Physicians of London has accredited this program with two credit hours (reference number: 19414).
The Italian Ministry of Health has accredited this CME activity with 1 credit.
